Home About Us Contact Us


Table of Content - Volume 20 Issue 2 - November 2021


Study of prevalence and factors associated among the patients of psoriasis at tertiary health care center


Kandaswamy M1, Suganthi S2*


1Associate Professor, Department of Dermatology Venereology and Leprosy, Melmaruvathur Adhiparasakthi Institute of Medical Sciences and Research, Melmaruvathur, Tamilnadu- 603319, INDIA.

2Associate Professor, Department of Community Medicine, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Chennai, Tamil Nadu-603103. INDIA.

Email: suganthikandaswamy@gmail.com



  1. Griffiths CEM, Camp RDR, Barker JNWN. Psoriasis, In- Rook’s Textbook of Dermatology,Burns T, Breathnach S, Cox N, Griffiths C editors, Seventh edition. Blackwell Science, Oxford. 2005;35(1)35-69.
  2. Dogra S, Yadav S. Psoriasis in India: Prevalence and pattern. Indian J Dermatol Venereol Leprol 2010; 76 : 595-601.
  3. Langley RGB, Krueger GG, Griffiths CEM. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005;64(Suppl II):ii18–23.      
  4. Ni C, Chiu MW. Psoriasis and comorbidities: Links and risks. Clin Cosmet Investig Dermatol 2014;7:119-32.
  5. Basko-Plluska J, Petronic-Rosic V. Psoriasis: epidemiology, natural history, and differential diagnosis. Psoriasis (Auckl). 2012;2:67-76
  6. Dogra S, Mahajan R. Psoriasis: Epidemiology, clinical features, co-morbidities, and clinical scoring. Indian Dermatol Online J 2016;7:471-80.
  7. Mohd Affandi A, Khan I, Ngah Saaya N. Epidemiology and Clinical Features of Adult Patients with Psoriasis in Malaysia: 10-Year Review from the Malaysian Psoriasis Registry (2007-2016). Dermatol Res Pract. 2018 Apr 23;2018:4371471.
  8. Sekar S, Daniel SJ. A clinico–epidemiological study of psoriasis patients with moderate to severe plaque type in tertiary care center in South India. Int J Res Dermatol 2020;7.
  9. Kumaraswamy SKA, Setty NKH, Nagaraja MS, et al. Profile of psoriasis among in-patients of dermatology department of a government tertiary care teaching hospital in Mysore: a medical record based study. J. Evolution Med. Dent. Sci. 2016;5(19):959-9
  10. Menter A, Korman NJ, Elmets CA. Guidelines of care for management of psoriasis and psoriatic arthritis. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol. 2011;65:137-74.
  11. Qureshi AA, Choi HK, Setty AR, Curhan GC. Psoriasis and the risk of diabetes and hypertension- a prospective study of US female nurses. Arch Dermatol. 2009;145(4)379-382.
  12. Belliappa Pemmanda Raju, Umashankar Nagaraju. Psoriasis Uncovered - Comorbid Conditions with Special Reference to Metabolic Syndrome. Our Dermatol Online. 2014; 5(1): 14-17.
  13. Lebwohl M. Psoriasis. Lancet 2003;361:1197- 204.
  14. Krueger G, Ellis CN. Psoriasis--recent advances in understanding its pathogenesis and treatment. J Am Acad Dermatol 2005;53:S94-100.
  15. Tsankov N, Irena A, Kasandjieva J. Drug-induced psoriasis: recognition and management. Am J Clin Dermatol 2000;1:159-65.
  16. Menter A, Gottlieb A, Feldman SR, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 2008; 58:826-850.
  17. Sampogna F, Tabolli S, Abeni D, IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) investigators.Living with psoriasis: prevalence of shame, anger, worry, and problems in daily activities and social life. Acta Derm Venereol. 2012;92(3):299–303.
  18. Devinder Mohan Thappa and Malathi Munisamy, Research on psoriasis in India: Where do we stand, Indian J Med Res 146, August 2017, pp 147-149.